Keywords: sanofi-aventis, uroxatral, improves, symptoms, bph, french, drug

Sanofi-Aventis' Uroxatral improves symptoms of BPH

Article | 06 June 2005

French drug major Sanofi-Aventis has released interim results from its ongoing, open-label study demonstrating that men treated with Uroxatral (alfuzosin) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Sanofi-Aventis

Go to company listing

Related Drugs

Alfuzosin HCl

Uroxatral

Go to drug listing